Track open bid opportunities, contracts, public meetings, and key contacts for University of Massachusetts Chan Medical School.
Active opportunities open for bidding
Posted
Jun 12, 2026
Dec 31, 2031
New Online Procurement System.
Key metrics and characteristics
City
The city where this buyer is located.
Worcester
Enrollment
Total student enrollment.
1,489
IPEDS ID
Integrated Postsecondary Education Data System identifier.
166708
Employee FTE
Full-time equivalent employees.
5,549
Propensity to Spend
How likely this buyer is to spend on new technology based on operating budget trends.
AI Adoption Score
How likely this buyer is to adopt new AI technologies.
Startup Friendliness
How often this buyer champions startups and early adoption.
Latest Budget Year
Unlock to view
Operating Budget
Unlock to view
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
AI-ranked best-fit opportunities before bid boards
Auto-drafted, compliance-ready outlines & boilerplate
Competitor & pricing intel from past awards
Native sync to Salesforce & HubSpot
Board meetings and strategic plans from University of Massachusetts Chan Medical School
This document details the addition of a Diversity, Equity, and Inclusion (DEI) pillar to UMass Chan Medical School's existing IMPACT 2025 Strategic Plan. The new pillar aims to integrate DEI across the institution by focusing on five priority areas: culture and climate, curriculum, education and engagement, equity within recruitment, retention and advancement, and improvement and accountability. The objective is to make DEI central to the institution's vision, ensure intentional efforts, and increase the representation of underrepresented groups, thereby moving from good intentions to measurable action.
The committee discussed several research protocols, including renewals and amendments involving molecular pathways in Frontotemporal dementia, virus-mediated gene transfer for cardiac arrhythmia treatment, circadian rhythm studies in Drosophila, HIV research, Hedgehog signaling pathways in organogenesis and tumorigenesis, ocular therapy pharmacology, antibody diversity mechanisms, skeletal homeostasis, and oligonucleotide therapeutics development. Additionally, the committee reviewed recent incidents regarding employee health services and received updates on ongoing studies.
Public-sector contacts connected to University of Massachusetts Chan Medical School.
The Institutional Biosafety Committee reviewed and discussed several research protocols, including renewals and amendments regarding microbial modulation, RNA-based therapeutics, and host-pathogen interactions. Key topics included the use of various viral vectors, CRISPR-mediated gene editing in different cell lines and animal models, and safety protocols for BSL-2 and BSL-3 facilities. The committee also addressed information regarding the movement of large animals between research facilities and received updates on clinical study protocols for immunotherapies and pneumococcal pneumonia research.
Extracted from official board minutes, strategic plans, and video transcripts.
Track University of Massachusetts Chan Medical School meetings, strategic plans, and budget discussions before the public bid appears.
Early signals from meeting minutes and plans
Vendor mentions and competitor tracking
Decision timeline from discussion to RFP
Quotable insights from buyer leadership
